Medicare supplier numbers, accreditation credentials, and established referral networks make acquisition the default choice for most serious HME buyers — but the math depends on your situation.
Starting or acquiring a Home Medical Equipment business are fundamentally different paths, and in this industry, the barriers to entry make that distinction more consequential than in most sectors. To bill Medicare and Medicaid — which represent the primary revenue source for most HME operators — you need an active supplier number, current ACHC or Joint Commission accreditation, state-specific licensing, and payor contracts that can take years to negotiate. Building all of that from zero is a multi-year undertaking with no revenue until every regulatory box is checked. Acquiring an existing HME provider, by contrast, gives you immediate access to billing infrastructure, a rental equipment fleet, trained staff, and referral relationships with hospitals and discharge planners. For buyers in the $1M–$5M revenue range, acquisition is typically the faster and often more capital-efficient path to a profitable operation — but only if you buy the right business and structure the deal to account for billing compliance risk and payor contract continuity.
Find Home Medical Equipment Businesses to AcquireAcquiring an established HME company gives you immediate access to the regulatory infrastructure, recurring revenue, and referral networks that take years to build from scratch. For buyers seeking cash flow within months rather than years, acquisition is almost always the more viable path in this heavily credentialed and compliance-driven industry.
Private equity-backed roll-up platforms, experienced healthcare operators, and entrepreneurial buyers with healthcare or distribution backgrounds who want cash-flowing operations and can navigate Medicare compliance complexity during due diligence.
Building an HME business from scratch offers full control over compliance culture, product mix, and geographic focus — but the regulatory credentialing process alone can delay billing for 12–24 months. For most buyers, the startup path is only viable as a niche or specialty-focused entry into markets with inadequate existing supply.
Clinicians or healthcare administrators with existing referral networks and deep DME operational experience who are targeting a specific underserved geography or product niche where no viable acquisition target exists.
For the vast majority of buyers targeting the $1M–$5M HME market, acquisition is the clear strategic choice. The combination of Medicare supplier number transfer, existing accreditation, active payor contracts, and a rental revenue base that cash flows from day one makes buying an established HME business dramatically more capital-efficient than a ground-up build when you account for the full cost of the credentialing timeline. The build path is only justifiable for operators with existing clinical relationships and a specific niche or territory where no acquisition target is available. Buyers should focus due diligence energy on Medicare billing compliance history, payor contract transferability, equipment fleet condition, and referral source dependency — these four factors determine whether an HME acquisition creates or destroys value in the first two years of ownership.
Do you have 18–30 months of operating capital to fund a startup through the Medicare credentialing and accreditation process before generating reimbursed revenue — or do you need cash flow within the first year?
Are there viable acquisition targets in your target geography with clean Medicare compliance histories, current accreditation, and diversified payor contracts, or is the market too thin to find a quality deal?
Do you have existing referral relationships with hospitals, discharge planners, or physician groups that would give a startup a meaningful head start on patient acquisition — and if not, how long would it take to build them?
Can you absorb the compliance and regulatory liability that comes with acquiring an existing Medicare supplier, and do you have the due diligence resources to identify hidden billing exposure before closing?
Is your strategic goal to build a single-location owner-operated business or to pursue a platform acquisition strategy — because the roll-up path almost always requires buying an established base with infrastructure that a startup cannot provide?
Browse Home Medical Equipment Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Expect 6–12 months for initial Medicare supplier enrollment, plus an additional 6–12 months to obtain ACHC or Joint Commission accreditation — both of which are required before you can bill Medicare for most DME categories. In total, a new HME startup should plan for 12–24 months before submitting its first reimbursed Medicare claim, making the build path a significant cash-burn period that most buyers underestimate.
Medicare supplier numbers are tied to the legal entity, not the physical location or product line. In most asset purchase transactions, the buyer must apply for a new supplier number or complete a change of ownership (CHOW) filing with the National Supplier Clearinghouse. The CHOW process typically takes 60–120 days and must be managed carefully to avoid billing interruptions. Your transaction attorney and billing compliance team should plan for this milestone well before closing.
Yes. HME acquisitions are generally SBA 7(a) eligible, and this is the most common financing structure for buyers in the $1M–$5M revenue segment. A typical deal structure involves a 10–20% buyer equity injection, an SBA 7(a) loan covering 60–70% of the purchase price, and a seller note covering the remaining gap. The SBA's focus on cash flow coverage means lenders will scrutinize the quality of recurring rental revenue and the stability of payor contracts during underwriting.
Undisclosed Medicare billing compliance liability is the single greatest risk in HME acquisitions. Open audits, prior authorization failures, upcoding patterns, or documentation deficiencies can result in post-close recoupment demands that fall on the buyer as the successor operator. A thorough pre-close compliance review — including a sample billing audit by a healthcare attorney or compliance consultant — is non-negotiable. Structure your deal with indemnification provisions and escrow holdbacks specifically tied to Medicare compliance exposure.
Referral relationships with hospitals, discharge planners, and physician groups are among the most valuable and most fragile assets in an HME business. Their transferability depends entirely on whether they are owned by the business (through contracts, dedicated staff, or institutional reputation) or by the owner personally. Seller transition support of 6–12 months, staff retention bonuses for key clinical and sales personnel, and earnout provisions tied to referral revenue continuity are all tools buyers use to protect against referral attrition after close.
Specialty niches can make the build path more defensible because they target patient populations and product categories where large HME roll-ups have less competitive focus and where clinical expertise creates a credible differentiation. However, you still face the same Medicare credentialing timeline and payor contracting challenges. If you have existing clinical credentials and referral relationships in a specialty area, a focused build may be viable — but you should still explore whether a partial acquisition or tuck-in of a small existing provider could accelerate your path to billing faster than starting from zero.
More Home Medical Equipment Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers